PUS3
Basic information
Region (hg38): 11:125893485-125903221
Links
Phenotypes
GenCC
Source:
- severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome (Moderate), mode of inheritance: AR
- severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with microcephaly and gray sclerae | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic; Ophthalmologic | 27055666; 28454995; 30308082; 32056211 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (6 variants)
- Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome (3 variants)
- Hydrolethalus syndrome (1 variants)
- Hydrolethalus syndrome 1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PUS3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 20 | 24 | ||||
missense | 61 | 73 | ||||
nonsense | 4 | |||||
start loss | 3 | |||||
frameshift | 6 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 2 | ||||
non coding | 32 | 116 | 160 | |||
Total | 8 | 10 | 97 | 140 | 18 |
Highest pathogenic variant AF is 0.000945
Variants in PUS3
This is a list of pathogenic ClinVar variants found in the PUS3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-125893814-C-T | Likely benign (Nov 01, 2024) | |||
11-125893822-C-T | Uncertain significance (Aug 21, 2022) | |||
11-125893827-C-T | Likely benign (Dec 11, 2023) | |||
11-125893850-T-G | Inborn genetic diseases | Uncertain significance (Aug 29, 2024) | ||
11-125893851-C-G | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome | Benign (Jan 31, 2024) | ||
11-125893862-G-A | Likely benign (Apr 09, 2018) | |||
11-125893870-T-C | Inborn genetic diseases | Uncertain significance (Oct 08, 2024) | ||
11-125893892-TTTC-T | Uncertain significance (Jul 14, 2022) | |||
11-125893903-T-C | Inborn genetic diseases | Uncertain significance (Sep 20, 2023) | ||
11-125893911-A-G | Likely benign (Sep 27, 2022) | |||
11-125893924-A-G | Inborn genetic diseases | Uncertain significance (Mar 06, 2023) | ||
11-125893928-G-A | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome | Pathogenic (Mar 14, 2024) | ||
11-125893930-C-T | Inborn genetic diseases | Uncertain significance (May 11, 2022) | ||
11-125893935-A-G | Likely benign (Aug 09, 2022) | |||
11-125893936-C-T | Inborn genetic diseases | Uncertain significance (Oct 17, 2024) | ||
11-125893937-G-A | Uncertain significance (Jul 17, 2023) | |||
11-125893941-A-C | Inborn genetic diseases | Uncertain significance (Aug 27, 2024) | ||
11-125893966-C-A | Inborn genetic diseases | Uncertain significance (Jun 18, 2021) | ||
11-125893967-C-T | PUS3-related disorder | Benign (Oct 14, 2023) | ||
11-125893981-C-T | Inborn genetic diseases | Uncertain significance (Oct 03, 2023) | ||
11-125893982-G-A | Inborn genetic diseases | Uncertain significance (Oct 20, 2024) | ||
11-125893989-G-C | Likely benign (Aug 24, 2023) | |||
11-125894006-G-A | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome | Uncertain significance (-) | ||
11-125894007-C-T | Inborn genetic diseases | Likely benign (Jan 24, 2024) | ||
11-125894011-T-C | Uncertain significance (Feb 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PUS3 | protein_coding | protein_coding | ENST00000227474 | 3 | 9736 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.40e-8 | 0.598 | 125696 | 0 | 52 | 125748 | 0.000207 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.134 | 261 | 267 | 0.977 | 0.0000143 | 3190 |
Missense in Polyphen | 65 | 69.548 | 0.9346 | 764 | ||
Synonymous | 0.134 | 88 | 89.6 | 0.982 | 0.00000426 | 906 |
Loss of Function | 1.16 | 15 | 20.7 | 0.724 | 0.00000142 | 208 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000459 | 0.000459 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000159 | 0.000158 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000686 | 0.000686 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Formation of pseudouridine at position 39 in the anticodon stem and loop of transfer RNAs. {ECO:0000269|PubMed:27055666}.;
- Disease
- DISEASE: Mental retardation, autosomal recessive 55 (MRT55) [MIM:617051]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:27055666}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- tRNA modification in the nucleus and cytosol;tRNA processing;Metabolism of RNA
(Consensus)
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.902
- rvis_EVS
- 0.24
- rvis_percentile_EVS
- 69.51
Haploinsufficiency Scores
- pHI
- 0.226
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.484
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0602
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pus3
- Phenotype
Gene ontology
- Biological process
- tRNA modification;tRNA pseudouridine synthesis;mRNA pseudouridine synthesis
- Cellular component
- nucleus;cytoplasm;cytosol
- Molecular function
- RNA binding;pseudouridine synthase activity;tRNA pseudouridine synthase activity